Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma

Growth Factor ◽

Epidermal Growth Factor ◽

Ovarian Carcinoma ◽

Aldehyde Dehydrogenase ◽

Poor Prognosis ◽

Growth Factor Receptor ◽

High Grade ◽

Serous Ovarian Carcinoma ◽

Epidermal Growth Factor Receptor Expression in Serous Ovarian Carcinoma: An Immunohistochemical Study With Galectin-3 and Cyclin D1 and Outcome

International Journal of Gynecological Pathology ◽

10.1097/pgp.0b013e31815d060d ◽

2008 ◽

Vol 27 (3) ◽

pp. 380-389 ◽

Cited By ~ 27

Author(s):

Hermann Brustmann

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Ovarian Carcinoma ◽

Immunohistochemical Study ◽

Growth Factor Receptor ◽

Receptor Expression ◽

Serous Ovarian Carcinoma ◽

Galectin 3 ◽

Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance

Iranian Journal of Cancer Prevention ◽

10.17795/ijcp-3428 ◽

2015 ◽

Vol 8 (4) ◽

Cited By ~ 11

Author(s):

Reza Ranjbar ◽

Foroogh Nejatollahi ◽

Ahmad Sina Nedaei Ahmadi ◽

Hossein Hafezi ◽

Akbar Safaie

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Ovarian Carcinoma ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Serous Ovarian Carcinoma ◽

Epidermal Growth ◽

Endothelial Growth Factor

Suppression of human epidermal growth factor receptor 2 via interference increases the chemosensitivity of ovarian carcinoma

Oncology Letters ◽

10.3892/ol.2016.4341 ◽

2016 ◽

Vol 11 (5) ◽

pp. 3028-3032 ◽

Cited By ~ 2

Author(s):

XIAOPING SONG ◽

KAILV SUN ◽

JIANMING HU ◽

JIANGHU ZHOU

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Ovarian Carcinoma ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Phosphorylation, But Not Overexpression, of Epidermal Growth Factor Receptor Is Associated With Poor Prognosis of Non-Small Cell Lung Cancer Patients

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ◽

10.3727/096504003108748348 ◽

2003 ◽

Vol 13 (5) ◽

pp. 289-298 ◽

Cited By ~ 52

Author(s):

Takanori Kanematsu ◽

Seiji Yano ◽

Hisanori Uehara ◽

Yoshimi Bando ◽

Saburo Sone

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Poor Prognosis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal growth factor receptor (EGF-R) in advanced ovarian carcinoma; lack of correlation between immunohistochemistry and biochemistry

European Journal of Cancer and Clinical Oncology ◽

10.1016/0277-5379(90)90466-7 ◽

1990 ◽

Vol 26 (2) ◽

pp. 190

Author(s):

S.C. Henzen-Logmans ◽

C.J. Rodenburg ◽

P.M.J.J. Berns ◽

M.E.L. v/d Burg ◽

J.G.M. Klijn ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Ovarian Carcinoma ◽

Growth Factor Receptor ◽

Advanced Ovarian Carcinoma ◽

AXL expression predicts poor prognosis and lack of efficacy of anti-angiogenic and anti-epidermal growth factor receptor (EGFR) agents in patients (pts) with RAS wild type (WT) metastatic colorectal cancer (mCRC)

Annals of Oncology ◽

10.1093/annonc/mdz239.032 ◽

2019 ◽

Vol 30 ◽

pp. v37-v38 ◽

Cited By ~ 1

Author(s):

C. Cardone ◽

B. Blauensteiner ◽

V. Moreno-Viedma ◽

P.P. Vitiello ◽

G. Martini ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Poor Prognosis ◽

Growth Factor Receptor ◽

Wild Type ◽

263 Up regulation of PD-L1 on peripheral blood CD3+ T cells predicts poor prognosis in patients with non-small cell lung cancer (NSCLC) treated with epidermal growth factor receptor (EGFR) inhibitors

European Journal of Cancer ◽

10.1016/s0959-8049(16)30148-4 ◽

2015 ◽

Vol 51 ◽

pp. S47

Author(s):

T. Meniawy ◽

R. Lake ◽

A. McDonnell ◽

M. Millward ◽

A. Nowak

Keyword(s):

Lung Cancer ◽

T Cells ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Poor Prognosis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6602149 ◽

2004 ◽

Vol 91 (7) ◽

pp. 1301-1307 ◽

Cited By ~ 33

Author(s):

D E B Swinson ◽

G Cox ◽

K J O'Byrne

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Poor Prognosis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Related Factors ◽

Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: Report from a phase I/II trial

Cancer Biology & Therapy ◽

10.4161/cbt.5.4.2522 ◽

2006 ◽

Vol 5 (4) ◽

pp. 375-379 ◽

Cited By ~ 89

Author(s):

Tania Crombet Ramos ◽

Javier Figueredo ◽

Mauricio Catala ◽

González Sandra ◽

Julio C. Selva ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Growth Factor Receptor ◽

High Grade Glioma ◽

High Grade ◽

Epidermal Growth ◽

Egfr Antibody

IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas

Cancer Letters ◽

10.1016/j.canlet.2019.05.028 ◽

2019 ◽

Vol 458 ◽

pp. 29-38 ◽

Cited By ~ 3

Author(s):

K. Mihajluk ◽

C. Simms ◽

M. Reay ◽

P.A. Madureira ◽

A. Howarth ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

High Grade ◽

Insulin Like Growth Factor ◽

Epidermal Growth ◽

High Grade Gliomas ◽

Inhibitor Resistance ◽

Receptor Inhibitor